Scholarlink

Background <p>Infectious complications remain a leading cause of mortality after hematopoietic stem cell transplantation (HSCT). We aimed to describe post-HSCT infections and their impact on survival in a center from a region with high antimicrobial resistance.</p> Methods <p>We included 522 patients with hematological malignancies undergoing HSCT at Koç University Hospital between 2016 and 2024. Bloodstream and opportunistic infections within 100 days were analyzed. Infection-related mortality (IRM) was defined as death primarily attributable to infectious complications. Predictors of 30- and 100-day mortality were assessed using multivariate logistic regression, including demographic and hematologic features, bloodstream infections (BSIs), invasive aspergillosis (IA), and cytomegalovirus reactivation.</p> Results <p>The most frequent diagnoses were non-Hodgkin lymphoma (36%), multiple myeloma (33%), and Hodgkin lymphoma (11%). Gram-negative bacteria (GNB) accounted for 73% of BSIs; <i>Escherichia coli</i> (31%) and <i>Klebsiella pneumoniae</i> (30%) were most frequent. Carbapenem resistance was highest in <i>Klebsiella pneumoniae</i> (67%), mainly due to OXA-48 carbapenemase (43%). Carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP) bacteremia was associated with significantly reduced 100-day survival (log-rank <i>p</i> &lt; 0.001). IA also significantly impaired survival in the overall cohort (log-rank <i>p</i> &lt; 0.001). In the allogeneic subgroup (<i>n</i> = 139), 100-day mortality reached 27%, with IA occurring in 19% and CRKP bacteremia in 17%.</p> <p>At 30 days, 25 patients (5%) had died; 24 of these deaths (96%) were attributed to infections. By day 100, 52 patients (10%) had died, and infections accounted for 42 deaths (80%).</p> Conclusion <p>In a high antimicrobial resistance setting, CRKP bacteremia and invasive aspergillosis were major determinants of early post-HSCT mortality. These findings highlight the need for optimized empirical therapy, antimicrobial stewardship, and strengthened infection prevention strategies in this vulnerable population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Infection-related mortality after hematopoietic stem cell transplantation in a high antimicrobial resistance setting

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月22日

查看全文
  • Pelin İrkören,
  • Sinem Civriz Bozdağ,
  • Ümit Barbaros Üre,
  • Nazlı Ataç,
  • Füsun Can,
  • Meltem Akay,
  • Önder Ergönül

摘要

Background

Infectious complications remain a leading cause of mortality after hematopoietic stem cell transplantation (HSCT). We aimed to describe post-HSCT infections and their impact on survival in a center from a region with high antimicrobial resistance.

Methods

We included 522 patients with hematological malignancies undergoing HSCT at Koç University Hospital between 2016 and 2024. Bloodstream and opportunistic infections within 100 days were analyzed. Infection-related mortality (IRM) was defined as death primarily attributable to infectious complications. Predictors of 30- and 100-day mortality were assessed using multivariate logistic regression, including demographic and hematologic features, bloodstream infections (BSIs), invasive aspergillosis (IA), and cytomegalovirus reactivation.

Results

The most frequent diagnoses were non-Hodgkin lymphoma (36%), multiple myeloma (33%), and Hodgkin lymphoma (11%). Gram-negative bacteria (GNB) accounted for 73% of BSIs; Escherichia coli (31%) and Klebsiella pneumoniae (30%) were most frequent. Carbapenem resistance was highest in Klebsiella pneumoniae (67%), mainly due to OXA-48 carbapenemase (43%). Carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteremia was associated with significantly reduced 100-day survival (log-rank p < 0.001). IA also significantly impaired survival in the overall cohort (log-rank p < 0.001). In the allogeneic subgroup (n = 139), 100-day mortality reached 27%, with IA occurring in 19% and CRKP bacteremia in 17%.

At 30 days, 25 patients (5%) had died; 24 of these deaths (96%) were attributed to infections. By day 100, 52 patients (10%) had died, and infections accounted for 42 deaths (80%).

Conclusion

In a high antimicrobial resistance setting, CRKP bacteremia and invasive aspergillosis were major determinants of early post-HSCT mortality. These findings highlight the need for optimized empirical therapy, antimicrobial stewardship, and strengthened infection prevention strategies in this vulnerable population.